http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102107001-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81d6af637871c95f327e1ea7d2593047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44d8a5137ddb620984395a86352e32e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a2dc7348231e1e074b3b813ec34c1bb |
| publicationDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102107001-B |
| titleOfInvention | Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
| abstract | The invention relates to application of liver X receptor (LXR) nuclear receptor agonist in the treatment and prevention of autoimmune diseases, in particular to application of a liver X receptor and/or cholesterol regulating element binding protein-1 in the preparation of a medicament for treating IL-17-mediated diseases and application of the liver X receptor and/or the cholesterol regulating element binding protein-1 in the preparation of a substance for regulating the differentiation of Th17 cells. The invention also relates to a method for regulating the differentiation of the Th17 cells in vitro and a method for screening the substance capable of regulating the differentiation of the Th17 cells. The invention also relates to the applied medicinal composition. |
| priorityDate | 2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.